Login

Setting the Benchmark for early-stage NSCLC prior to the introduction of Immunotherapy

This study used real-world data from the Queensland Oncology Repository for the period 2011-2017 to document baseline patterns of treatment and outcomes, including stage specific survival, for diagnosis years prior to the introduction of immunotherapy.  These results will allow us to monitor incremental change as new therapies for early-stage NSCLC are introduced.